About Index Trending news
Analyze
Pricing
HemoGenyx

HemoGenyx

Work at HemoGenyx? Add yourself to this profile

HemoGenyx

HemoGenyx, a privately held biopharmaceutical company, is developing new sources of hemogenic cells for hematopoietic system regeneration.
Edit Profile
More info

Elsewhere

Companies in the same industry

Pearl Therapeutics Pearl Therapeutics Pharmapod Pharmapod Thar Pharmaceuticals Thar Pharmaceuticals EnBiotix, Inc. EnBiotix, Inc. Nuo Therapeutics Nuo Therapeutics Rgenix Rgenix ApoGen Biotechnologies ApoGen Biotechnologies Faraday Pharmaceuticals, Inc. Faraday Pharmaceuticals, Inc. Hazel Technologies Hazel Technologies Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals

Alexa global traffic share

Twitter followers

Terms of Service API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 2
Add info
Latest funding
Seed fund
$1,000,000
Seed fund
$250,000
Employees

Unknown size

Locations
HQ
United States
Headquarters

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when HemoGenyx makes some noise.